iGene is a pioneer in Digital Autopsy utilising a software solution that revolutionises the post mortem examination –
a practice that has seen little change over centuries.
Over 200,000 deaths in the UK each year require further medical or legal investigation and the majority result in invasive post- mortem procedures, adding further stress for family and friends at an already emotional time particularly in those cultures with a preference for not interfering with the deceased.
Using the Digital Autopsy technology developed by iGene, the deceased is digitised using a CT scanner. In little more than 10 minutes the data from the scan is processed to create a detailed 3D whole body reconstruction of the body. Specially trained radiologists and pathologists can then examine the findings directly with a better accuracy than traditional practices.
The vision of iGene is to ensure that this breakthrough achieves a total leap forward from the conventional practices of autopsy. The company hopes in future that every case will be digitalised using scanning methods to produce multiple applications that will meet the needs of the government, administrators and which will serve the public at large. The technology also provides possibilities to innovate with medical education.
CommonwealthFirst will work with iGene to raise their profile and transform post mortem practices across the Commonwealth.
CommonwealthFirst supports SMEs to trade and invest across the Commonwealth. The programme is developed by a partnership between the Commonwealth Enterprise and Investment Council and Royal Mail with the support from i-genius as implementation partner.